Exosomes as Theranostics for Lung Cancer

Area of Science:

• * Genetics and Genomics
• * Oncology
• * Nanotechnology

Background:

• * Lung cancer is a complex, heterogeneous disease often diagnosed at advanced stages.
• * Conventional treatments and targeted therapies face challenges like poor tumor targeting and resistance.
• * Effective drug delivery systems are crucial for improving lung cancer treatment outcomes.

Purpose of the Study:

• * To summarize the current applications of exosomes in lung cancer theranostics.
• * To highlight the potential of exosomes as drug delivery vehicles and diagnostic tools.
• * To explore the use of exosomes in liquid biopsy for lung cancer detection.

Main Methods:

• * Review of current research on exosome-based theranostics for lung cancer.
• * Analysis of exosome properties for drug delivery and molecular diagnosis.
• * Examination of exosome applications in imaging and liquid biopsy.

Main Results:

• * Exosomes naturally transport biomolecules, making them suitable for drug delivery.
• * Exosomes can be functionalized with nanoparticles for enhanced imaging.
• * Exosomes are emerging as key components in liquid biopsy for cancer detection.

Conclusions:

• * Exosomes offer a promising platform for developing novel lung cancer therapies and diagnostics.
• * Further research into exosome-based theranostics can overcome limitations of current treatments.
• * Exosomes have broad applicability in both therapeutic delivery and early cancer detection.